Disease-Modifying Therapies Remain Underused in SCD Despite Safety and Efficacy
ASH Research Collaborative study finds that only one-quarter of patients living with SCD are prescribed a DMT
ASH Research Collaborative Press Releases
ASH Research Collaborative study finds that only one-quarter of patients living with SCD are prescribed a DMT